Litcius/Paper detail

A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1–7 (TXA-127) for the treatment of severe COVID-19

Gebhard Wagener, Monica Goldklang, Adam Gerber, Katerina Elisman, Katherine A. Eiseman, Laura D. Fonseca, Jeanine D’Armiento

2022Critical Care28 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)Double blindedPlacebo2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Randomized controlled trialEmergency medicineInternal medicineAnesthesiaVirologyAlternative medicinePathologyOutbreakDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchCOVID-19 and Mental Health
A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1–7 (TXA-127) for the treatment of severe COVID-19 | Litcius